Advances in the treatment and prognosis of anaplastic lymphoma kinase negative anaplastic large cell lymphoma

被引：6
|
作者：
Wang, Xiaoli [1 ]
Wu, Jingjing [1 ]
Zhang, Mingzhi [1 ]
机构：
[1] Zhengzhou Univ, Affiliated Hosp 1, Dept Oncol, Lymphoma Diag & Treatment Ctr Henan Prov, Zhengzhou, Henan, Peoples R China
来源：
HEMATOLOGY | 2019年 / 24卷 / 01期
关键词：
Anaplastic large cell lymphoma; anaplastic lymphoma kinase; treatment; prognosis; PIVOTAL PHASE-II; BRENTUXIMAB VEDOTIN; OPEN-LABEL; ALK; DISEASE; TRANSPLANTATION; MULTICENTER; DOXORUBICIN; ADULTS; ERA;
D O I：
10.1080/16078454.2019.1613290
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Anaplastic lymphoma kinase negative anaplastic large cell lymphoma (ALK- ALCL) is a definite entity in the WHO 2016 Classification that represents 2-3% of non-Hodgkin lymphoma (NHL) and 12% of T-cell NHL cases. ALK- ALCL lacks ALK protein expression, but expresses CD30 and has morphologic features similar to ALK positive anaplastic large cell lymphoma (ALK+ ALCL). Some studies indicate that ALK- ALCL and ALK+ ALCL possess different molecular and genetic characteristics. Besides, ALK- ALCL is worse than ALK+ ALCL in terms of treatment outcome, prognosis, and long-term survival. This review is aimed at summarizing information about ALK- ALCL, especially with respect to the treatment and prognosis.
引用
收藏
页码：440 / 445
页数：6
相关论文
共 50 条
  • [31] Brentuximab Vedotin and Crizotinib in Anaplastic Large-Cell Lymphoma
    Foyil, Kelley V.
    Bartlett, Nancy L.
    CANCER JOURNAL, 2012, 18 (05) : 450 - 456
  • [32] An Exploration into the Origins and Pathogenesis of Anaplastic Large Cell Lymphoma, Anaplastic Lymphoma Kinase (ALK)-Positive
    Turner, Suzanne D.
    CANCERS, 2017, 9 (10)
  • [33] Anaplastic Lymphoma Kinase- and CD30-Positive Anaplastic Large-Cell Lymphoma of the External Auditory Canal
    Chen, Shih-Lung
    Chan, Kai-Chieh
    DIAGNOSTICS, 2021, 11 (07)
  • [34] Successful allogeneic stem cell transplantation for an adult with refractory anaplastic lymphoma kinase - Positive anaplastic large cell lymphoma
    Chen, Chao-Hsun
    Chen, Shan-Wen
    Shen, Wan-Lin
    Chen, Tsai-Yun
    Tsao, Chao-Jung
    Huang, Wen-Tsung
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2007, 85 (02) : 105 - 107
  • [35] Successful allogeneic stem cell transplantation for an adult with refractory anaplastic lymphoma kinase—positive anaplastic large cell lymphoma
    Chao-Hsun Chen
    Shan-Wen Chen
    Wan-Lin Shen
    Tsai-Yun Chen
    Chao-Jung Tsao
    Wen-Tsung Huang
    International Journal of Hematology, 2007, 85 : 105 - 107
  • [36] Crizotinib in Combination with Everolimus Synergistically Inhibits Proliferation of Anaplastic Lymphoma Kinase - Positive Anaplastic Large Cell Lymphoma
    Xu, Wendan
    Kim, Ji-Won
    Jung, Woo June
    Koh, Youngil
    Yoon, Sung-Soo
    CANCER RESEARCH AND TREATMENT, 2018, 50 (02): : 599 - 613
  • [37] Anaplastic lymphoma kinase-positive primary cutaneous anaplastic large cell lymphoma- Is it a new variant?
    Kumaran, Muthu Sendhil
    Jithendriya, Madhukara
    Nagaraj, Preethi
    Tirumalae, Rajalakshmi
    Jayaseelan, Elizabeth
    INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY, 2012, 78 (03) : 354 - 357
  • [38] Brentuximab vedotin for refractory anaplastic lymphoma kinase-negative anaplastic large cell lymphoma in leukemic phase with RUNX3 overexpression
    Yamashita, Yusuke
    Hori, Yoshikazu
    Kosako, Hideki
    Oiwa, Takehiro
    Warigaya, Kenji
    Mushino, Toshiki
    Murata, Shogo
    Fujimoto, Masakazu
    Nishikawa, Akinori
    Murata, Shin-ichi
    Sonoki, Takashi
    Tamura, Shinobu
    HEMATOLOGY REPORTS, 2020, 12 (01)
  • [39] Beyond NPM-anaplastic lymphoma kinase driven lymphomagenesis: alternative drivers in anaplastic large cell lymphoma
    Tabbo, Fabrizio
    Ponzoni, Maurilio
    Rabadan, Raul
    Bertoni, Francesco
    Inghirami, Giorgio
    CURRENT OPINION IN HEMATOLOGY, 2013, 20 (04) : 374 - 381
  • [40] Combined Modality Management of Sinonasal Anaplastic Lymphoma Kinase Negative Anaplastic Large Cell Lymphoma in a Geriatric Patient-Report of a Rare Case
    Ahitagni Biswas
    Sorun Shishak
    Swarnaditya Roy
    Aanchal Kakkar
    Head and Neck Pathology, 2021, 15 : 1335 - 1344
12345